ESUR GUIDELINES ON CONTRAST MEDIA VERSION 7 PDF

“Contrast agents are much less nephrotoxic than previously thought”, said Aart van der the current ESUR Contrast Media Safety Committee (CMSC) guideline. Renal adverse reactions to gadolinium-based contrast agents B How long should there be between two iodine-based contrast media injections for routine. The Contrast Media Safety Committee of the European Society of Urogenital Radiology is proud to present the 10th version of its Contrast Agent Guidelines.

Author: Dukinos Akijora
Country: Sudan
Language: English (Spanish)
Genre: Science
Published (Last): 20 July 2006
Pages: 14
PDF File Size: 2.22 Mb
ePub File Size: 17.68 Mb
ISBN: 555-9-79134-794-3
Downloads: 79312
Price: Free* [*Free Regsitration Required]
Uploader: Kijar

Contrast media :

Pateints with heart failure NYHA or end stage renal failure should get individualized hydration. Almost reports from international congresses Hundreds of summaries from the leading radiology journals Videos and interviews with radiologists from all contrrast the world. Use preventive hydration before contrast medium administration see ‘Elective examination’ for protocols.

To avoid the risk of NSF refer to 1. High osmolality ionic contrast media.

Sign Up for free now and gain access to Detailed information about the use of cookies on this website can be found in our Privacy Statement Cookie Settings. Guidelines Meticulous angiographic technique is mandatory and is the most important factor in reducing thromboembolic complications. Van der Molen also stressed that implementing guidelines in his hospital was a joint effort, involving all doctors.

  CARRIER 42EM PDF

Keep a proper record of the contrast medium injection time, dose, name. In pediatric patients give 0. However, there is no evidence that hemodialysis protects patients with impaired renal function cotrast contrast medium induced nephropathy or nephrogenic systemic fibrosis. Previous late contrast medium reaction. You can manage or withdraw your consent at any time. All iodine- and gadolinium-based contrast agents can be removed by hemodialysis or peritoneal dialysis.

Mandatory These agents should never be given in higher doses than 0.

Never deny a patient a clinically well- indicated enhanced MRI examination. Intravenous saline and bicarbonate protocols have similar efficacy for preventive hydration. Renal adverse reactions to iodine-based contrast media B. Known or suspected acute renal failure. Our monthly Newsletter informs you about News at radiology.

ESUR Guidelines

See renal adverse reactions see 2. No special precautions are necessary when diabetic patients on metformin are given gadolinium-based contrast medium.

Intravenous cholangiographic contrast media should not be given to patients at risk. Measure guidelinees within 48 hours and restart metformin if renal function has not changed significantly. In this case, three precautionary steps should be followed:.

  ESTIMATION AND COSTING IN CIVIL ENGINEERING BY B.N. DUTTA PDF

Test injection with normal saline. When there is a very strong indication for enhanced MR, the medi possible dose of one of the most stable gadolinium contrast agents see Contrast agents: The clinically important adverse effect of iodine-based contrast media on blood and endothelium is thrombosis. Consider an alternative test not requiring a gadolinium-based contrast agent. Patch and delayed reading intradermal tests may be useful to confirm a late skin reaction to contrast medium and to study cross- reactivity patterns with other agents.

Clinical features of NSF. Following administration of gadolinium-based agents to contrawt mother during pregnancy, no neonatal tests are necessary. Large doses of contrast medium given intra-arterially with first pass renal exposure.

Late adverse reactions to intravascular iodinated contrast media. Prophylaxis is generally not necessary. To reduce the risk. Discuss the need to stop nephrotoxic drugs with the referring physician. Use a different gadolinium-based agent for previous reactors to contrast medium. Refer to renal adverse reactions section 2.